Roche Holding AG (RHHBY)
52.75
-0.44
(-0.83%)
USD |
OTCM |
Sep 11, 16:00
Roche Market Cap : 291.21B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 291.21B |
| September 10, 2026 | 293.64B |
| September 09, 2026 | 294.69B |
| September 08, 2026 | 298.50B |
| September 04, 2026 | 303.44B |
| September 03, 2026 | 304.85B |
| September 02, 2026 | 297.17B |
| September 01, 2026 | 293.09B |
| August 31, 2026 | 296.46B |
| August 28, 2026 | 304.68B |
| August 27, 2026 | 311.31B |
| August 26, 2026 | 314.07B |
| August 25, 2026 | 322.79B |
| August 24, 2026 | 317.27B |
| August 21, 2026 | 320.75B |
| August 20, 2026 | 316.05B |
| August 19, 2026 | 321.30B |
| August 18, 2026 | 306.53B |
| August 17, 2026 | 301.48B |
| August 14, 2026 | 300.98B |
| August 13, 2026 | 306.34B |
| August 12, 2026 | 311.97B |
| August 11, 2026 | 312.58B |
| August 10, 2026 | 317.05B |
| August 07, 2026 | 316.11B |
| Date | Value |
|---|---|
| August 06, 2026 | 310.09B |
| August 05, 2026 | 311.42B |
| August 04, 2026 | 305.95B |
| August 03, 2026 | 304.07B |
| July 31, 2026 | 301.81B |
| July 30, 2026 | 305.12B |
| July 29, 2026 | 303.47B |
| July 28, 2026 | 312.02B |
| July 27, 2026 | 302.36B |
| July 24, 2026 | 301.98B |
| July 23, 2026 | 297.67B |
| July 22, 2026 | 285.41B |
| July 21, 2026 | 282.32B |
| July 20, 2026 | 281.08B |
| July 17, 2026 | 284.39B |
| July 16, 2026 | 283.56B |
| July 15, 2026 | 282.07B |
| July 14, 2026 | 276.45B |
| July 13, 2026 | 278.33B |
| July 10, 2026 | 286.04B |
| July 09, 2026 | 286.70B |
| July 08, 2026 | 285.27B |
| July 07, 2026 | 287.53B |
| July 06, 2026 | 284.33B |
| July 02, 2026 | 292.33B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 251.08B |
| AstraZeneca PLC | 496.79B |
| Merck & Co., Inc. | 355.31B |
| Pfizer Inc. | 157.98B |
| Eli Lilly & Co. | 1.050T |
Market Cap Related Metrics
| PE Ratio | 21.82 |
| PS Ratio | 4.422 |
| PEG Ratio | 0.7322 |
| Price to Free Cash Flow | 20.75 |
| Price | 52.75 |
| Earnings Yield | 4.58% |
| PEGY Ratio | 0.6665 |
| Operating PE Ratio | 14.42 |
| Normalized PE Ratio | 18.29 |